Cargando…

Clinical outcomes after whole-genome sequencing in patients with metastatic non-small-cell lung cancer

The Personalized Onco-Genomics (POG) program at BC Cancer integrates whole-genome (DNA) and RNA sequencing into practice for metastatic malignancies. We examined the subgroup of patients with metastatic non-small-cell lung cancer (NSCLC) and report the prevalence of actionable targets, treatments, a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsang, Erica S., Shen, Yaoqing, Chooback, Negar, Ho, Cheryl, Jones, Martin, Renouf, Daniel J., Lim, Howard, Sun, Sophie, Yip, Stephen, Pleasance, Erin, Ionescu, Diana N., Mungall, Karen, Kasaian, Katayoon, Ma, Yussanne, Zhao, Yongjun, Mungall, Andrew, Moore, Richard, Jones, Steven J.M., Marra, Marco, Laskin, Janessa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory Press 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6371742/ https://www.ncbi.nlm.nih.gov/pubmed/30514790 http://dx.doi.org/10.1101/mcs.a002659

Ejemplares similares

Personalized oncogenomic analysis of metastatic adenoid cystic carcinoma: using whole-genome sequencing to inform clinical decision-making
por: Chahal, Manik, et al.
Publicado: (2018)

Lessons learned from the application of whole-genome analysis to the treatment of patients with advanced cancers
por: Laskin, Janessa, et al.
Publicado: (2015)

The pivotal role of sampling recurrent tumors in the precision care of patients with tumors of the central nervous system
por: Wong, Derek, et al.
Publicado: (2019)

Application of a Neural Network Whole Transcriptome–Based Pan-Cancer Method for Diagnosis of Primary and Metastatic Cancers
por: Grewal, Jasleen K., et al.
Publicado: (2019)

Whole genome and whole transcriptome genomic profiling of a metastatic eccrine porocarcinoma
por: Thibodeau, My Linh, et al.
Publicado: (2018)

Fluorouracil sensitivity in a head and neck squamous cell carcinoma with a somatic DPYD structural variant
por: Majounie, Elisa, et al.
Publicado: (2020)

NTRK2 Fusion driven pediatric glioblastoma: Identification of oncogenic Drivers via integrative Genome and transcriptome profiling
por: Britton, Heidi M., et al.
Publicado: (2021)

Improved structural variant interpretation for hereditary cancer susceptibility using long-read sequencing
por: Thibodeau, My Linh, et al.
Publicado: (2020)

Molecular etiology of an indolent lymphoproliferative disorder determined by whole-genome sequencing
por: Parker, Jeremy D.K., et al.
Publicado: (2016)

The genomic and transcriptomic landscape of anaplastic thyroid cancer: implications for therapy
por: Kasaian, Katayoon, et al.
Publicado: (2015)

Whole-genome and transcriptome profiling of a metastatic thyroid-like follicular renal cell carcinoma
por: Ko, Jenny J., et al.
Publicado: (2018)

TMBur: a distributable tumor mutation burden approach for whole genome sequencing
por: Titmuss, Emma, et al.
Publicado: (2022)

Corrigendum: Genomic profiling of pelvic genital type leiomyosarcoma in a woman with a germline CHEK2:c.1100delC mutation and a concomitant diagnosis of metastatic invasive ductal breast carcinoma
por: Thibodeau, My Linh, et al.
Publicado: (2018)

Homologous recombination deficiency signatures in gastrointestinal and thoracic cancers correlate with platinum therapy duration
por: Tsang, Erica S., et al.
Publicado: (2023)

The impact of whole genome and transcriptome analysis (WGTA) on predictive biomarker discovery and diagnostic accuracy of advanced malignancies
por: Tessier‐Cloutier, Basile, et al.
Publicado: (2022)

Genomic profiling of pelvic genital type leiomyosarcoma in a woman with a germline CHEK2:c.1100delC mutation and a concomitant diagnosis of metastatic invasive ductal breast carcinoma
por: Thibodeau, My Linh, et al.
Publicado: (2017)

Putative BRAF activating fusion in a medullary thyroid cancer
por: Kasaian, Katayoon, et al.
Publicado: (2016)

Base excision repair deficiency signatures implicate germline and somatic MUTYH aberrations in pancreatic ductal adenocarcinoma and breast cancer oncogenesis
por: Thibodeau, My Linh, et al.
Publicado: (2019)

Molecular characterization of metastatic pancreatic neuroendocrine tumors (PNETs) using whole-genome and transcriptome sequencing
por: Wong, Hui-li, et al.
Publicado: (2018)

Genomic characterization of a well-differentiated grade 3 pancreatic neuroendocrine tumor
por: Williamson, Laura M., et al.
Publicado: (2019)

Response to angiotensin blockade with irbesartan in a patient with metastatic colorectal cancer
por: Jones, M. R., et al.
Publicado: (2016)

Comparative RNA-Sequencing Analysis Benefits a Pediatric Patient With Relapsed Cancer
por: Newton, Yulia, et al.
Publicado: (2018)

Detection and genomic characterization of a mammary-like adenocarcinoma
por: Grewal, Jasleen K., et al.
Publicado: (2017)

Whole-genome and transcriptome analysis of advanced adrenocortical cancer highlights multiple alterations affecting epigenome and DNA repair pathways
por: Lavoie, Jean-Michel, et al.
Publicado: (2022)

Tumor infiltrating neutrophils and gland formation predict overall survival and molecular subgroups in pancreatic ductal adenocarcinoma
por: Naso, Julia R., et al.
Publicado: (2020)

Matching methods in precision oncology: An introduction and illustrative example
por: Weymann, Deirdre, et al.
Publicado: (2020)

Personalized Oncogenomics: Clinical Experience with Malignant Peritoneal Mesothelioma Using Whole Genome Sequencing
por: Sheffield, Brandon S., et al.
Publicado: (2015)

Molecular characterization of ERBB2-amplified colorectal cancer identifies potential mechanisms of resistance to targeted therapies: a report of two instructive cases
por: Owen, Daniel R., et al.
Publicado: (2018)

Application of genomics to identify therapeutic targets in recurrent pediatric papillary thyroid carcinoma
por: Ronsley, Rebecca, et al.
Publicado: (2018)

Rearrangement-mediated cis-regulatory alterations in advanced patient tumors reveal interactions with therapy
por: Zhang, Yiqun, et al.
Publicado: (2021)

Clinical and cost outcomes following genomics‐informed treatment for advanced cancers
por: Weymann, Deirdre, et al.
Publicado: (2021)

A platform for oncogenomic reporting and interpretation
por: Reisle, Caralyn, et al.
Publicado: (2022)

The cost and cost trajectory of whole‐genome analysis guiding treatment of patients with advanced cancers
por: Weymann, Deirdre, et al.
Publicado: (2017)

Establishing a Framework for the Clinical Translation of Germline Findings in Precision Oncology
por: Dixon, Katherine, et al.
Publicado: (2020)

Early-stage economic analysis of research-based comprehensive genomic sequencing for advanced cancer care
por: Weymann, Deirdre, et al.
Publicado: (2021)

Large-scale profiling of microRNAs for The Cancer Genome Atlas
por: Chu, Andy, et al.
Publicado: (2016)

Retrospective review using targeted deep sequencing reveals mutational differences between gastroesophageal junction and gastric carcinomas
por: Li-Chang, Hector H, et al.
Publicado: (2015)

MicroRNA Expression-Based Model Indicates Event-Free Survival in Pediatric Acute Myeloid Leukemia
por: Lim, Emilia L., et al.
Publicado: (2017)

The Genome of the Northern Sea Otter (Enhydra lutris kenyoni)
por: Jones, Samantha J., et al.
Publicado: (2017)

Defining the heterogeneity of unbalanced structural variation underlying breast cancer susceptibility by nanopore genome sequencing
por: Dixon, Katherine, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_m17ggv2fg500nqa6mosde9jaia